Bain Capital, Mitsubishi Tanabe Pharma

Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory change for Japan's drug industry.
Bain to acquire Mitsubishi Tanabe Pharma in $3.3 billion deal
Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous system and metabolic disease.
Bain Is Said to Near $3 Billion Deal for Mitsubishi Pharma Unit
Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter said, adding to a dealmaking boom in Japan.
Bain Capital to Buy Mitsubishi Chemical’s Pharma Business for More Than $3 Billion
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a bid to focus on its key businesses.
Mitsubishi Chemical to sell drug unit to Bain in $3.36 billion deal
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it seeks to streamline its portfolio.
Bain Capital to buy Mitsubishi Chemical’s pharma unit for $3.3B
Investment firm Bain Capital said on Friday that it has signed an agreement to acquire Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group (OTCPK:MTLHY) for approximately 510 billion JPY (3.3 billion USD).
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ("Tanabe Pharma", "MTPC" or "the Company") in a carve-out transaction from Mitsubishi Chemical Group Corporation.
Mitsubishi books $342 million charge on Japan offshore wind projects
Japan's Mitsubishi Corp took a 52.2 billion yen ($342.4 million) impairment charge on its domestic offshore wind projects in ...
Nikkei Asia2d
It's crunch time for Japan's Buffett-backed trading houses
TOKYO -- Japan's trading houses stand at a critical juncture less than two years after receiving a personal visit and ...
The Mitsubishi MU-2: A Look At Japan’s Most Successful Post-War Aircraft
Despite production ending in 1986, the aircraft is still flying around today and is popular due to its dependability and ...
Japan's Mitsubishi 9-month net profit up 19% y/y
Japan's Mitsubishi Corp posted on Thursday a 19% increase in nine-month net profit to December to 827.4 billion yen ($5.43 ...
Power Technology on MSN4d
Mitsubishi takes $342.4m impairment charge on domestic offshore wind
Mitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.
Mitsubishi is speeding towards a financial cliff
Mitsubishi Motors is facing a tough financial year, with the company slashing its net profit forecast by a staggering 76%.
Mitsubishi reviews Japan offshore wind projects amid market shifts
Mitsubishi Corp on Monday said it is reviewing how to proceed with its offshore wind projects in Japan given a "significantly ...
Mitsubishi Reviews Japanese Offshore Wind After Economic Changes
Mitsubishi Corp. is reviewing business plans for three Japanese offshore wind power projects following macroeconomic changes, ...